Busulfan description

Busulfan is achemotherapy biologic frequently used to adapt accouchement for cartilage bottom transplantation. In the past, Busulfan was taken by aperture as a bolus or, in adolescent children, administered through a bendable agriculture tube through the adenoids into the stomach. More recently, an intravenous (IV) alertness of busulfan has become available. Busulfan is used to accomplish amplitude in the bottom to acquiesce donor beef to grow, or engraft.

Busulfan was accustomed by the US Food and Biologic Administration (FDA) for analysis of abiding myeloid leukemia (CML) in 1999. Busulfan was the mainstay of the chemotherapeutic analysis of abiding myeloid leukemia (CML) until it was displaced by the new gold standard, imatinib, admitting it is still in use to a amount as a aftereffect of the drug's about low cost.

Busulfan is used to amusement cancer. It is generally included in pre-transplant chemotherapy. In patients with leukemia and lymphoma, busulfan is used to abort blight beef and the absolute cartilage marrow. This biologic is accustomed by aperture or in the attitude (IV).